Flickering LEDs could light the way for new Alzheimer’s treatment
December 8, 2016Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice
Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …
European thumbs up for Abbvie leukaemia drug
December 8, 2016Medical Communications, Sales and Marketing AbbVie, Venclyxto
Abbvie has confirmed its Venclyxto (venetoclax) has been granted marketing authorisation by the European Commission (EC) as a monotherapy for …
Novartis’ drug doubly effective as chemotherapy for treating lung cancer
December 8, 2016NSCLC, Novartis, chemotherapy
Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced …
Teva embroiled in internal bribery investigation
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery
Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …
Mylan to restructure and slash around 10% of workforce
December 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses
Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …
BMS shares promising Opdivo/Yervoy data for advanced bladder cancer
December 8, 2016Research and Development BMS, Yervoy, opdivo
BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …
New Alzheimer’s research edges closer to treatment & prevention
December 7, 2016Research and Development Alzheimer's
A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …
AbbVie links up with Johns Hopkins University in cancer research
December 7, 2016Medical Communications
AbbVie has announced that it has agreed a five-year collaboration agreement with Johns Hopkins University. The aim of the collaboration …
AstraZeneca’s Lisa Anson appointed president of ABPI
December 7, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
Janssen reveals positive results from longest follow-up of Imbruvica
December 7, 2016Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica
Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …
Novo pledges single-digit cap on drug price hikes
December 7, 2016Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk
Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …
Pfizer slapped with record £84.2 million fine for 2,600% price increase
December 7, 2016Medical Communications, Research and Development CMA, Flynn Pharma, Pfizer, fine
Pfizer has been hit with a record fine by The Competition and Markets Authority for the increase in the price …
AZ lung cancer drug cuts disease progression by 70%
December 7, 2016Research and Development AstraZeneca, Tagrisso
AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …
Veeva releases key details from European Life Sciences Survey
December 6, 2016veeva
Veeva, which held its European Life Sciences Summit last week, has announced some of the key findings from its European …
Shire given permission for $400 million biologics manufacturing facility
December 6, 2016Manufacturing and Production, Research and Development Co Meat, Ireland, Shire
Shire has received planning permission for a new state-of-the-art biologics manufacturing facility in Co Meath, Ireland. The plant will be …
CMO of OncoMed Pharma resigns
December 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
OncoMed Pharmaceuticals, a clinical-stage pharmaceutical company, announced that Jakob Dupont has resigned from his positions as the company’s senior vice …
CEO of Teva’s Generics Medicines Group steps down
December 6, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva
Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Cannabis-based treatment scores Phase 3 successes for GW Pharma
December 6, 2016Manufacturing and Production, Research and Development GW Pharma, cannabidiol
UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
CEO of Teva’s Generics Medicines Group steps down
December 6, 2016Manufacturing and Production, Medical Communications Teva, generics
Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO
December 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic
Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
